Medicure (OTCMKTS:MCUJF) Share Price Passes Above 50-Day Moving Average – Should You Sell?

Medicure Inc. (OTCMKTS:MCUJF)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.75 and traded as high as $0.8081. Medicure shares last traded at $0.8081, with a volume of 200 shares.

Medicure Stock Down 4.2%

The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.73 and a current ratio of 1.04. The stock’s fifty day simple moving average is $0.75 and its two-hundred day simple moving average is $0.81. The company has a market capitalization of $8.44 million, a price-to-earnings ratio of -1.72 and a beta of 1.02.

Medicure (OTCMKTS:MCUJF) last released its earnings results on Thursday, May 21st. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.01. The business had revenue of $5.79 million for the quarter, compared to the consensus estimate of $3.63 million. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.